The typical genomic feature of acute myeloid leukemia (AML) M3 subtype is the fusion event of PML/RARα, and ATRA/ATO-based combination therapy is current standard treatment regimen for M3 subtype.
Source link
You may also like
LXer: Install Python 3.11 && PyCharm on openSUSE Tumbleweed (kernel 6.7.2)
Generative AI: Transforming Photography’s Future
The Pathway to Artificial General Intelligence (AGI) and the Era of Broad AI
Modeling of Machine Learning-Based Extreme Value Theory in Stock Investment Risk Prediction: A Systematic Literature Review
Preparing for the Generative AI Era: CloudThat’s Strategic Readiness
